Isovaleryl-CoA dehydrogenase

Last updated
isovaleryl-CoA dehydrogenase
1ivh.jpg
Isovaleryl-CoA dehydrogenase tetramer, Human
Identifiers
EC no. 1.3.8.4
CAS no. 37274-61-6
Databases
BRENDA enzyme data
ExPASy NiceZyme view
KEGG enzyme entry
MetaCyc metabolic pathway
Rhea reactions
PDB structures RCSB PDB PDBe PDBsum
Gene Ontology AmiGO / QuickGO
Search
PMC articles
PubMed articles
NCBI proteins
IVD
Identifiers
Aliases IVD , IVDH, ACAD2, isovaleryl-CoA dehydrogenase
External IDs OMIM: 607036; MGI: 1929242; GeneCards: IVD
Available structures
PDB Ortholog search: PDBe RCSB
Enzyme activity
EC # BRENDA ExPASy KEGG MetaCyc
1.3.8.1 ↗ ↗ ↗ ↗
1.3.8.4 ↗ ↗ ↗ ↗
Orthologs
Databases NCBI: entry; OMA: entry
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_019826

RefSeq (protein)

NP_062800

Location (UCSC) Chr 15: 40.41 – 40.44 Mb Chr 2: 118.69 – 118.71 Mb
PubMed search [3] [4]
Wikidata
View/Edit Human View/Edit Mouse

Isovaleryl-CoA dehydrogenase (EC 1.3.8.4) is an enzyme that in humans is encoded by the gene IVD. More generally, it refers to any enzyme that catalyzes the chemical reaction

Contents

3-methylbutanoyl-CoA + acceptor ⇌ 3-methylbut-2-enoyl-CoA + reduced acceptor

Thus, the two substrates of this enzyme are 3-methylbutanoyl-CoA and acceptor, whereas its two products are 3-methylbut-2-enoyl-CoA and reduced acceptor.

This enzyme belongs to the family of oxidoreductases, specifically those acting on the CH-CH group of donor with other acceptors. The systematic name of this enzyme class is 3-methylbutanoyl-CoA:acceptor oxidoreductase. Other names in common use include isovaleryl-coenzyme A dehydrogenase, isovaleroyl-coenzyme A dehydrogenase, and 3-methylbutanoyl-CoA:(acceptor) oxidoreductase. This enzyme participates in valine, leucine and isoleucine degradation. It employs one cofactor, FAD.

Structural studies

As of late 2007, only one structure has been solved for this class of enzymes, with the PDB accession code PDB: 1IVH ​. It was created by a group containing K.A.Tiffany, D.L.Roberts, M.Wang, R.Paschke, A.-W.A.Mohsen, J.Vockley, and J.J.P.Kim. The structure was released on May 20, 1998.Doe. "PDBsum entry: 1ivh" . Retrieved November 25, 2019.

Leucine metabolism

References

  1. 1 2 3 GRCh38: Ensembl release 89: ENSG00000128928 – Ensembl, May 2017
  2. 1 2 3 GRCm38: Ensembl release 89: ENSMUSG00000027332 – Ensembl, May 2017
  3. ↑ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ↑ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. 1 2 Wilson JM, Fitschen PJ, Campbell B, Wilson GJ, Zanchi N, Taylor L, Wilborn C, Kalman DS, Stout JR, Hoffman JR, Ziegenfuss TN, Lopez HL, Kreider RB, Smith-Ryan AE, Antonio J (February 2013). "International Society of Sports Nutrition Position Stand: beta-hydroxy-beta-methylbutyrate (HMB)". Journal of the International Society of Sports Nutrition. 10 (1): 6. doi: 10.1186/1550-2783-10-6 . PMC   3568064 . PMID   23374455.
  6. 1 2 Kohlmeier M (May 2015). "Leucine". Nutrient Metabolism: Structures, Functions, and Genes (2nd ed.). Academic Press. pp. 385–388. ISBN   978-0-12-387784-0 . Retrieved 6 June 2016. Energy fuel: Eventually, most Leu is broken down, providing about 6.0kcal/g. About 60% of ingested Leu is oxidized within a few hours ... Ketogenesis: A significant proportion (40% of an ingested dose) is converted into acetyl-CoA and thereby contributes to the synthesis of ketones, steroids, fatty acids, and other compounds
    Figure 8.57: Metabolism of L-leucine